Illuminating AD/ADRD Genome to Enable Precision Genomic Medicine

US · IL National Institutes of Health (NIH) grant unknown #RFA-AG-26-023

Summary

This is a forecasted federal grant opportunity from the National Institutes of Health (NIH) focused on illuminating the Alzheimer's Disease (AD) and Alzheimer's Disease Related Dementias (ADRD) genome to enable precision genomic medicine. The opportunity is identified under RFA-AG-26-023, suggesting it is administered through the National Institute on Aging (NIA). Full programmatic details, award amounts, and eligibility requirements are not yet published, as the opportunity is in forecasted status.

What they want

Technical requirements

Research must address AD/ADRD genomics
Scope implies precision genomic medicine approaches for Alzheimer's Disease and related dementias

Risks & flags

Opportunity is in 'forecasted' status — full solicitation details, eligibility, and award parameters are not yet available; limited intelligence can be extracted
No dollar values, deadlines, or scope details published — risk of incomplete competitive assessment at this stage

Market context

inferred from NAICS

Professional, Scientific & Technical Services

NAICS 541711

US market size: $2.0T
Typical award: $25K – $50M

Typical buyers

All federal civilianDoDStates

Commonly required

8(a)WOSBSDVOSBPE/PMP

Sector-level estimate — full code lookup not yet in catalog.

Illuminating AD/ADRD Genome to Enable Prec…

$unknown

Onboard ↗